Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Bit Digital
BTBT
$520M
| $1.29M | ﹤0.01% |
681,991
-224,492
| -25% | -$649K |
|
3227
Colony Bankcorp
CBAN
$471M
| $1.28M | ﹤0.01% |
72,076
+3,742
| +5% | +$63.4K |
|
3228
Cooper-Standard Automotive
CPS
$484M
| $1.28M | ﹤0.01% |
39,013
+2,546
| +7% | +$82.9K |
|
3229
Manitowoc
MTW
$753M
| $1.28M | ﹤0.01% |
106,784
+16,695
| +19% | +$190K |
|
3230
4D Molecular Therapeutics
FDMT
$609M
| $1.28M | ﹤0.01% |
170,639
+76,811
| +82% | +$779K |
|
3231
Miller Industries
MLR
$640M
| $1.28M | ﹤0.01% |
34,219
+5,854
| +21% | +$228K |
|
3232
Oil States International
OIS
$526M
| $1.28M | ﹤0.01% |
188,604
+4,295
| +2% | +$27.6K |
|
|
BDN
3233
Brandywine Realty Trust
BDN
$542M
| $1.28M | ﹤0.01% |
437,111
+51,898
| +13% | +$177K |
|
3234
Civista Bancshares
CIVB
$595M
| $1.27M | ﹤0.01% |
57,358
+2,755
| +5% | +$60.9K |
|
3235
Bankwell Financial Group
BWFG
$542M
| $1.27M | ﹤0.01% |
27,795
+3,755
| +16% | +$170K |
|
3236
SmartFinancial
SMBK
$899M
| $1.27M | ﹤0.01% |
34,384
+5,358
| +18% | +$194K |
|
3237
CALL
First Majestic Silver
AG
$9.26B
| $1.27M | ﹤0.01% |
+76,100
| New | +$1.06M |
|
3238
Choiceone Financial
COFS
$515M
| $1.27M | ﹤0.01% |
42,943
+3,518
| +9% | +$104K |
|
|
TRTX
3239
TPG RE Finance Trust
TRTX
$616M
| $1.27M | ﹤0.01% |
146,959
-1,440
| -1% | -$12.8K |
|
|
WLAC
3240
DELISTED
Willow Lane Acquisition Corp
WLAC
| $1.26M | ﹤0.01% |
+100,000
| New | +$1.23M |
|
3241
Kearny Financial
KRNY
$604M
| $1.26M | ﹤0.01% |
170,552
+15,872
| +10% | +$110K |
|
3242
Prime Medicine
PRME
$575M
| $1.26M | ﹤0.01% |
363,826
+247,926
| +214% | +$1.1M |
|
|
FFIC
3243
DELISTED
Flushing Financial
FFIC
| $1.26M | ﹤0.01% |
83,143
+9,844
| +13% | +$149K |
|
3244
PUT
Natera
NTRA
$44.8B
| $1.26M | ﹤0.01% |
5,500
| – | – |
|
|
SMLR
3245
DELISTED
Semler Scientific
SMLR
| $1.26M | ﹤0.01% |
82,363
+5,688
| +7% | +$129K |
|
3246
FLEX LNG
FLNG
$1.64B
| $1.26M | ﹤0.01% |
50,462
+5,075
| +11% | +$129K |
|
|
GDEN
3247
DELISTED
Golden Entertainment
GDEN
| $1.26M | ﹤0.01% |
46,255
-1,042
| -2% | -$27K |
|
3248
Green Dot
GDOT
$770M
| $1.26M | ﹤0.01% |
98,014
+11,073
| +13% | +$138K |
|
3249
Ichor Holdings
ICHR
$2.67B
| $1.25M | ﹤0.01% |
67,891
+19,996
| +42% | +$371K |
|
3250
indie Semiconductor
INDI
$875M
| $1.25M | ﹤0.01% |
354,100
+80,924
| +30% | +$355K |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.